Valuation: Terumo Corporation

Market Cap 3,301B 21.03B 18.34B 17.32B 15.72B 29.46B 2,018B 29.58B 207B 80.04B 1,026B 79B 77.25B P/E 2027 *
16.7x
P/E 2028 * 17x
Enterprise Value 3,347B 21.32B 18.59B 17.56B 15.94B 29.87B 2,046B 30B 210B 81.16B 1,040B 80.1B 78.33B EV / Sales 2027 *
2.66x
EV / Sales 2028 * 2.44x
Free-Float
97.07%
Yield 2027 *
1.66%
Yield 2028 * 1.81%
1 day-2.33%
1 week-0.36%
Current month-11.05%
1 month-13.19%
3 months-0.93%
6 months+5.29%
Current year-1.41%
1 week 2,228.5
Extreme 2228.5
2,313.5
1 month 2,194.5
Extreme 2194.5
2,645.5
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.33%-0.36%-11.58%+1.66% 21.69B
+0.37%+0.65%-23.75%+1.59% 177B
-0.69%+1.29%-3.62%+11.27% 119B
-0.20%-3.98%+6.17%+72.47% 59.04B
-0.24%+1.74%-3.94%-31.61% 49.41B
-0.22%-0.37%+7.26%+35.20% 48.64B
+1.61%+7.61%+17.91%-6.24% 33.18B
-1.49%-2.74% - - 28.18B
-1.17%+4.64%+42.09%-8.18% 25.8B
+1.02%+5.99%+7.20%-19.54% 21.91B
Average -0.33%+1.75%+4.19%+6.29% 58.34B
Weighted average by Cap. -0.17%+0.94%-4.54%+9.43%

Financials

2027 *2028 *
Net sales 1,259B 8.02B 6.99B 6.6B 6B 11.23B 770B 11.28B 79.1B 30.52B 391B 30.13B 29.46B 1,340B 8.54B 7.45B 7.03B 6.38B 11.96B 819B 12.01B 84.21B 32.5B 417B 32.08B 31.36B
Net income 195B 1.24B 1.08B 1.02B 929M 1.74B 119B 1.75B 12.26B 4.73B 60.65B 4.67B 4.57B 194B 1.23B 1.08B 1.02B 922M 1.73B 118B 1.74B 12.17B 4.7B 60.18B 4.63B 4.53B
Net Debt 45.99B 293M 255M 241M 219M 410M 28.11B 412M 2.89B 1.12B 14.29B 1.1B 1.08B -26.39B -168M -147M -138M -126M -236M -16.13B -237M -1.66B -640M -8.2B -632M -618M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
18/09/26 JPY 2,238.00 -2.33% 6,326,500
17/09/26 JPY 2,291.50 +2.12% 3,177,500
16/09/26 JPY 2,244.00 +0.07% 2,879,300
15/09/26 JPY 2,242.50 -0.88% 2,588,100
14/09/26 JPY 2,262.50 +0.73% 6,110,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,238.00JPY
Average target price
3,165.00JPY
Spread / Average Target
+41.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!